Arya Sciences Acquisition Corp V Cl A (ARYE)
Arya Sciences Acquisition Corp V Cl A (ARYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 385 | 776 | N/A | N/A |
| TOTAL | $542 | $1,237 | $N/A | $N/A |
| Non-Current Assets | ||||
| Investments And Advances | 151,602 | 149,531 | 0 | 0 |
| TOTAL | $151,602 | $149,531 | $N/A | $N/A |
| Total Assets | $152,144 | $150,767 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 90 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 12 | 13 | 0 | 0 |
| Accrued Expenses | 2,776 | 2,704 | N/A | N/A |
| TOTAL | $2,878 | $2,716 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 154,118 | 154,733 | 0 | 0 |
| TOTAL | $154,118 | $154,733 | $N/A | $N/A |
| Total Liabilities | $156,996 | $157,449 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 19,187 | 19,187 | N/A | N/A |
| Retained earnings | -4,852 | -6,682 | N/A | N/A |
| TOTAL | $-4,852 | $-6,681 | $N/A | $N/A |
| Total Liabilities And Equity | $152,144 | $150,767 | $0 | $0 |